Evidence map›Paper›PMID 35684439›Full record

ArticleMolecules (Basel, Switzerland)2022

Himanshu Kakkar, Nalini Chaudhary, Devashish Mehta, Varsha Saini, Shallu Maheshwari, Jitender Singh, Preeti Walia, Avinash Bajaj

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  3. Frontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Himanshu KakkarLord Shiva College of Pharmacy, Near Civil Hospital, Sirsa 125055, Haryana, India.
Nalini ChaudharyLaboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad 121001, Haryana, India.
Devashish MehtaLaboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad 121001, Haryana, India.
Varsha SainiLaboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad 121001, Haryana, India.
Shallu MaheshwariLord Shiva College of Pharmacy, Near Civil Hospital, Sirsa 125055, Haryana, India.
Jitender SinghLord Shiva College of Pharmacy, Near Civil Hospital, Sirsa 125055, Haryana, India.
Preeti WaliaLaboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad 121001, Haryana, India.
Avinash BajajLaboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad 121001, Haryana, India.
Regional Centre for Biotechnology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections associated with Gram-positive bacteria like

Indexed as

Methicillin-Resistant Staphylococcus aureusWound InfectionAnimalsAnti-Bacterial AgentsBacteriaBenzimidazolesBiofilmsCholic AcidMiceMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsBenzimidazolesCholic Acidantimicrobial resistancecholic acidmembrane targeting amphiphilesS. aureus

Identifiers

PMID35684439
PMCPMC9182351
OpenAlexW4281626133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.